Tailoring therapy and maximising TAVI programme efficiency

845

In this educational supplement, sponsored by Boston Scientific, Cardiovascular News explores the use of transcatheter aortic valve implantation (TAVI), including latest developments in techniques and approaches.

  • Lars Søndergaard charts the evolution of TAVI and considers patient tailored TAVI to optimise outcomes and efficiency
  • Oliver Husser discusses how transcatheter heart valve selection may aid a reduction in pacemaker rates after TAVI
  • Nicolas van Mieghem discusses how its low pacemaker rate makes ACURATE neo an attractive device to use in early discharge setting
  • Michel Noutsias and Stefan Toggweiler present case experience using the ACURATE neo
  • Georg Goliasch, Christian Hengstenberg and Julia Mascherbauer share details of TAVI in a patient with horizontal aortic root, using cerebral protection

Note: This supplement is not intended for distribution in France, Japan and USA.


LEAVE A REPLY

Please enter your comment!
Please enter your name here